The diabetes prevention program: Baseline characteristics of the randomized cohort

Diabetes Care

Volumn 23, Issue 11, 2000, Pages 1619-1629

  Bray, G A ^a   Culbert, I W ^a   Champagne, C M ^a   Dawson, L ^a   Eberhardt, B ^a   Greenway, F L ^a   Guillory, F G ^a   Hebert, A A ^a   Jeffirs, M L ^a   Kennedy, B M ^a   Lovejoy, J C ^a   Melancon, L E ^a   Morris, L H ^a   Perault, J ^a   Ryan, D H ^a   Sanford, D A ^a   Smith, K G ^a   Smith, L L ^a   St Amant, J A ^a   Tucker, E ^a   Tulley, R T ^a   Vicknair, P C ^a   Williamson, D ^a   Zachwieja, J J ^a   Tobian, J A ^a   Matulik, M J ^a   Clarke, B ^a   Collins, D A ^a   Czech, K B ^a   DeSandre, C ^a   Ehrmann, D A ^a   Geiger, G ^a   Harding Clay, B ^a   Hilbrich, R M ^a   McNabb, W L ^a   Polonsky, K S ^a   Semenske, A R ^a   Stepp, K A ^a   Watson, P G ^a   Mendoza, J T ^a   Smith, K A ^a   Goldstein, B J ^a   Lark, C ^a   Liberoni, R ^a   Murphy, L ^a   Pepe, C ^a   Spandorfer, J M ^a   Goldberg, R B ^a   Rowe, P ^a   Calles, J ^a   Casanova, P ^a   Donahue, R P ^a   Florez, H J ^a   Giannella, A ^a   McLymont, V ^a   Mendez, J ^a   O'Hara, P ^a   Ojito, J ^a   Prineas, R ^a   Haffner, S M ^a   Montez, M G ^a   Miettinen, H ^a   Mobley, C M ^a   Mykkanen, L A ^a   Rozek, M M ^a   Hamman, R F ^a   Nash, P V ^a   Calonge, B N ^a   Hill, J O ^a   Hoyer, S R ^a   Jortberg, B T ^a   Miller Stone, M ^a   Regensteiner, J G ^a   Seagle, H ^a   Steinke, S C ^a   Testaverde, L ^a   Van Dorsten, B ^a   Horton, E S ^a   Lawton, K E ^a   Arky, R A ^a   Bryant, M ^a   Burke, J P ^a   Caballero, E ^a   Callaghan, K M ^a   Ganda, O P ^a   Franklin, T ^a   Jackson, S D ^a   Jacobsen, A M ^a   Kula, L M ^a   Kocal, M ^a   Malloy, M A ^a   Nicosia, M ^a   Oldmixon, C F ^a   Pan, J ^a   Quitingon, M ^a   Rubtchinsky, S ^a   Seely, E W ^a   Schweizer, D ^a   more..

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO; TROGLITAZONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0033760858     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.11.1619     Document Type: Article

References (48)

1. The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes
2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
3. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation
4. Impaired glucose tolerance
5. The natural history of impaired glucose tolerance in the Pima Indians
6. Increased skeletal muscle capillary density precedes diabetes development in men with impaired glucose tolerance
7. Stability over time of modem diagnostic criteria for type II diabetes
8. Transient impaired glucose tolerance in Pima Indians: Is it important?
9. The natural history of impaired glucose tolerance in the Micronesian population of Nauru: A six-year follow-up study
10. Predictors of progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus: An analysis of six prospective studies
11. Ten-year follow-up of subjects with impaired glucose tolerance: Prevention of diabetes by tolbutamide and diet regulation
12. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
13. Diabetes mellitus and macrovascular complications: An epidemiological perspective
14. Screening for diabetes (Position Statement)
15. Epidemiology, obesity and non-insulin-dependent diabetes mellitus
16. Risk factors for non-insulin-dependent diabetes
17. Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus
18. Statistical considerations in the intent-to-treat principle
19. Diabetes Prevention Program: The U.S. type 2 diabetes prevention trial
20. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults
21. Fatness, fat distribution, and glucose tolerance in second-generation Japanese American (Nisei) men
22. Evaluation of the hexokinase-glucose-6-phosphate deydrogenase method of determination of glucose in urine
23. An automated high pressure liquid-chromatographic assay for hemoglobin Alc
24. Enzymatic methods for quantification of lipoprotein lipids
25. 2+ precipitation procedure for quantification of high-density lipoprotein cholesterol
26. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
27. Methodology of ECG interpretation in the Dalhousie Program: NOVACODE ECG classification procedures for clinical trials and population health surveys
28. NOVACODE serial ECG classification system for clinical trials and epidemiological studies
29. The ten-year follow-up of the Bedford Survey (1962-1972): Glucose tolerance and diabetes
30. Worsening to diabetes in men with impaired glucose tolerance ('borderline diabetes')
31. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution
32. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise: The 6-year Malmo feasibility study
33. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study
34. Glucose tolerance and mortality, including a substudy of tolbutamide treatment
35. Plasma insulin among Nauruans: Prediction of deterioration in glucose tolerance over 6 years
36. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men
37. Prevention of type II diabetes in subjects with impaired glucose tolerance: The Diabetes Prevention Study (DPS) in Finland: Study design and 1-year interim report on the feasibility of the lifestyle intervention programme
38. The STOP-NIDDM Trial: An international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: Rationale, design, and preliminary screening data
39. Relationship of glycosolated hemoglobin to oral glucose tolerance: Implications for diabetes screening
40. Biological variation of glycated hemoglobin: Implications for diabetes screening and monitoring
41. Reproducibility of HbA(1c) in a healthy adult population: The Telecom Study